Home > Compound List > Product Information
α5IA_Molecular_structure_CAS_215874-86-5)
Click picture or here to close

α5IA

Catalog No. A2734 Name Sigma Aldrich
CAS Number 215874-86-5 Website http://www.sigmaaldrich.com
M. F. C17H14N8O2 Telephone 1-800-521-8956
M. W. 362.34546 Fax
Purity ≥98% (HPLC) Email
Storage Chembase ID: 130268

SYNONYMS

IUPAC name
1-methyl-4-({[3-(5-methyl-1,2-oxazol-3-yl)-[1,2,4]triazolo[3,4-a]phthalazin-6-yl]oxy}methyl)-1H-1,2,3-triazole
IUPAC Traditional name
Α5IA
Synonyms
3-(5-Methylisoxazol-3-yl)-6-(1-methyl-1,2,3-triazol-4-yl)methoxy-1,2,4-triazolo[3,4-a]phthalazine
1,2,4-Triazolo[3,4-a]phthalazine, 3-(5-methyl-3-isoxazolyl)-6-[(1-methyl-1H-1,2,3-triazol-4-yl)methoxy]-

DATABASE IDS

MDL Number MFCD09832717
CAS Number 215874-86-5

PROPERTIES

Empirical Formula (Hill Notation) C17H14N8O2
Purity ≥98% (HPLC)
Apperance off-white to light yellow powder
Solubility DMSO: >2 mg/mL
MSDS Link Download
Personal Protective Equipment Eyeshields, Gloves, type N95 (US), type P1 (EN143) respirator filter
Storage Temperature 2-8°C
German water hazard class 3

DETAILS

Description (English)
Biochem/physiol Actions
α5IA is a selective inverse agonist for Α5 subtype of GABAA receptor with a higher intrinsic activity at the A5 subtype than other drugs. α5IA enhances cognition in laboratory animals without being proconvulsant or anxiogenic. α5IA acts as an "alcohol antagonist," markedly reducing the amnesic effect of alcohol and partially attenuating sedation, similar to Ro15-4513, but without the anxiogenic effect. α5IA offers promise as a tool to study cognitive disorders, memory function, and treatment of alcohol-related disorders.
Description (简体中文)
Biochem/physiol Actions
α5IA is a selective inverse agonist for Α5 subtype of GABAA receptor with a higher intrinsic activity at the A5 subtype than other drugs. α5IA enhances cognition in laboratory animals without being proconvulsant or anxiogenic. α5IA acts as an "alcohol antagonist," markedly reducing the amnesic effect of alcohol and partially attenuating sedation, similar to Ro15-4513, but without the anxiogenic effect. α5IA offers promise as a tool to study cognitive disorders, memory function, and treatment of alcohol-related disorders.

REFERENCES